RLAY — Relay Therapeutics Share News
0.000.00%
- $3.19bn
- $2.55bn
- $15.36m
Relay Therapeutics Inc expected to post a loss of 77 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-AES Corp, Applied DNA Sciences, health insurers
U.S. STOCKS ON THE MOVE-Centrus Energy, Williams-Sonoma, uranium miners
U.S. STOCKS ON THE MOVE-Cantaloupe, Children's Place, GameStop
U.S. STOCKS ON THE MOVE-Coinbase Global, GameStop, Trump Media & Technology Group
Relay Therapeutics drops on deep-discounted $200 mln equity offering
Brief: Relay Therapeutics Prices Public Offering Of 28.57 Mln Shares At $7 Each
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Relay Therapeutics retreats on planned equity offering
U.S. RESEARCH ROUNDUP-Apple, Fedex, Vaxcyte
Brief: Relay Therapeutics Inc Files For Common Stock Offering Of Up To $200 Million - SEC Filing
Brief: Relay Therapeutics Announces Proposed Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Teekay, Brenmiller Energy, JetBlue
Relay rises as combo breast cancer therapy cuts disease progression in early study
U.S. STOCKS ON THE MOVE-Teekay, Brenmiller Energy, JetBlue
Newscasts - Trading at Noon: Wall Street recovers some of last week's losses
Relay Therapeutics' combo therapy cuts breast cancer progression in early study (updated)
Relay rises as combo breast cancer therapy cuts disease progression in early study